WHC is still in active development. Read this to understand our approach.
depiction of ZWWRREXSUJTKNN-UHFFFAOYSA-N.svg
isomerdesign

CP 47,497

Verificar en isomerdesign

isomerdesign

(S,S)-epi-CP 47,497

Verificar en isomerdesign

isomerdesign

(R,R)-epi-CP 47,497

Verificar en isomerdesign

isomerdesign

(1R,3S) CP 47,497

Verificar en isomerdesign

pubchem

2-[(1r,3s)-3-Hydroxy...

Verificar en pubchem

drugmap

CP-4497

Verificar en drugmap

wiki

CP 47,497

Verificar en wiki

Data

InChI: InChI=1S/C21H34O2/c1-4-5-6-7-13-21(2,3)17-11-12-19(20(23)15-17)16-9-8-10-18(22)14-16/h11-12,15-16,18,22-23H,4-10,13-14H2,1-3H3

Sinónimos: 2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol,Phenol, 5-(1,1-dimethylheptyl)-2-[(1r,3s)-3-hydroxycyclohexyl]-,J-520105,J-505191,CP 47497,CCG-208720,(R,R)-epi-CP 47,497,(cis)-3-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]cyclohexanol,HSDB 8001,CP-47,497 (C7),DTXSID401009968,cis-3-(2-Hydroxy-4-(1,1-dimethylheptylphenyl)-cyclohexan-1-ol),3-(2-hydroxy-4-(1,1-dimethylheptylphenyl)cyclohexan-1-ol),cis-3-[4-(1,1-dimethylheptyl) 2-hydroxyphenyl]cyclohexanol,FAPQAUKC04,5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol,(+)-CP-47497,(S,S)-epi-CP 47,497,CP 47,497,DEA No.7297,SCHEMBL11166255,DTXSID201017793,2-[(1r,3s)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol,2-[(1S,3S)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol,2-((1R,3S)-3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol,CP-47,497,cis-3-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]cyclohexanol,(1R,3S) CP 47,497,CP47,497,AKOS027324391,(+)-CP 47,497,CHEBI:191114,CP-47497,70434-82-1,UNII-FAPQAUKC04,ZINC5820249,CP47497,(+-)-CP 47497,3-(4-(1,1-Dimethylheptyl)-2-hydroxyphenyl)cyclohexanol

Estimated data

Solubilidad: -5.161 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 79.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.